Comparing quality of life improvement after antegrade continence enema (ACE) therapy for patients with organic and functional constipation / encopresis.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
May 2022
Historique:
received: 28 12 2021
accepted: 30 12 2021
pubmed: 5 2 2022
medline: 20 4 2022
entrez: 4 2 2022
Statut: ppublish

Résumé

We compared patient- and family-reported overall and stool-related quality of life (QoL) before and after an antegrade continence enema (ACE) procedure (cecostomy tube insertion) for refractory chronic constipation or fecal incontinence (CCFI). We hypothesized that patients with functional diagnoses experience similar improvements in QoL compared to those with organic diagnoses. This is a cross-sectional study of patients undergoing cecostomy tube insertion for CCFI at a tertiary pediatric hospital from 2012 to 2019. Patients and/or primary caregivers completed validated stooling and overall QoL surveys based on three time points: before surgery, three months after surgery, and at the time of survey / date of last follow-up. Repeated measures analyses compared scores over time between subjects and within the diagnostic groups. The response rate was 65% (22/34 patients, 12 organic and 10 functional diagnoses). Mean age was 8.3 years and 32% of the participants were female. Organic diagnoses were: spina bifida (6), anorectal malformation (5), and Hirschsprung Disease (1). There was substantial improvement in stool-related and overall QoL at three months post-ACE procedure (both p<0.001) for all patients; both scores continued to improve significantly until the date of last follow-up (median 4.1 years, IQR 2.3-5.6, p<0.001). There was no statistically significant difference in scores between patients with organic and functional diagnoses. Caregivers perceive a significant, sustainable improvement in stooling habits and QoL following ACE therapy. The improvement is comparable between patients with a functional diagnosis and those with an underlying organic reason for their CCFI.

Sections du résumé

BACKGROUND BACKGROUND
We compared patient- and family-reported overall and stool-related quality of life (QoL) before and after an antegrade continence enema (ACE) procedure (cecostomy tube insertion) for refractory chronic constipation or fecal incontinence (CCFI). We hypothesized that patients with functional diagnoses experience similar improvements in QoL compared to those with organic diagnoses.
METHODS METHODS
This is a cross-sectional study of patients undergoing cecostomy tube insertion for CCFI at a tertiary pediatric hospital from 2012 to 2019. Patients and/or primary caregivers completed validated stooling and overall QoL surveys based on three time points: before surgery, three months after surgery, and at the time of survey / date of last follow-up. Repeated measures analyses compared scores over time between subjects and within the diagnostic groups.
RESULTS RESULTS
The response rate was 65% (22/34 patients, 12 organic and 10 functional diagnoses). Mean age was 8.3 years and 32% of the participants were female. Organic diagnoses were: spina bifida (6), anorectal malformation (5), and Hirschsprung Disease (1). There was substantial improvement in stool-related and overall QoL at three months post-ACE procedure (both p<0.001) for all patients; both scores continued to improve significantly until the date of last follow-up (median 4.1 years, IQR 2.3-5.6, p<0.001). There was no statistically significant difference in scores between patients with organic and functional diagnoses.
CONCLUSIONS CONCLUSIONS
Caregivers perceive a significant, sustainable improvement in stooling habits and QoL following ACE therapy. The improvement is comparable between patients with a functional diagnosis and those with an underlying organic reason for their CCFI.

Identifiants

pubmed: 35115169
pii: S0022-3468(22)00032-X
doi: 10.1016/j.jpedsurg.2021.12.055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

855-860

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Shawn Brophy (S)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada.

Kelly Brennan (K)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada.

Emily Woodgate (E)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada.

Bridget Pinaud (B)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada.

Elizabeth McLaughlin (E)

IWK Health, Pediatric Health Psychology Service, Halifax, Nova Scotia, Canada.

Joanne Gillespie (J)

IWK Health, Pediatric Health Psychology Service, Halifax, Nova Scotia, Canada.

Zubin Grover (Z)

IWK Health, Dalhousie University, Division of Pediatric Gastroenterology, Department of Pediatrics, Halifax, Nova Scotia, Canada.

Christopher Blackmore (C)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada.

Rodrigo Lp Romao (RL)

IWK Health, Dalhousie University, Division of Pediatric General and Thoracic Surgery, Department of Surgery, 5980 University Avenue, P.O. Box 9700, Halifax, Nova Scotia B3K 6R8, Canada; IWK Health, Dalhousie University, Division of Pediatric Urology, Department of Urology, Halifax, Nova Scotia, Canada. Electronic address: rodrigo.romao@dal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH